Certified by Founder Lodge
SEQUENTIAL
United States - New York City
START UP
1 Disclosed Funding Rounds $3,500,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sequential advances personal care and health research by studying the real-world impact of products through human clinical testing, biomarker discovery, and next-generation formulations acros
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 18 ,2026 | Unknown | $3,500,000 |
SOSV
Scrum Ventures
Corundum Systems Biology
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Quorus | $5,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
